Sign Out
Patients with severe infections such as sepsis, tuberculosis and opportunistic infections (see Warnings and Precautions).
Patients with moderate or severe (NYHA class III/IV) congestive heart failure (see Precautions).
Patients who are hypersensitive to golimumab, or any other ingredient in the formulation or component of the container. For a complete listing, see Description.
Continue with Google